Mice with an R619W knock-in transgene (which corresponds to the human autoimmune-associated R620W alteration) exhibit better control of xenografted Hepa1-6.x1 tumor growth than wildtype mice, but less effectively than Ptpn22-deficient mice (75, 81). Here, PTPN22 is linked to neoplasm.